Nephrotoxicity Caused by Oral Antiviral Agents in Patients With Chronic Hepatitis B Treated in a Hospital for Tropical Diseases in Thailand

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/s40360-015-0037-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effect of Newer Oral Antiviral Agents on Future Therapy of Chronic Hepatitis B

Antiviral Therapy
Infectious DiseasesPharmacology
2010English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

FRI0181 Tapering or Cessation of Antiviral Agent in Hepatitis B Virus-Infected Patients Concomitantly Treated With Biologic Agents

2017English

New Oral Direct-Acting Antiviral Agents for Treatment of Chronic Hepatitis-C Infection in Patients With Chronic Kidney Disease Including Dialysis Patients and Kidney Transplant Recipients

SM Journal of Nephrology and Therapeutics
2017English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Hepatitis B Reactivation and Outcomes in Persons Treated With Directly Acting Antiviral Agents Against Hepatitis C Virus: Results From ERCHIVES

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

A Cost-Utility Analysis of Drug Treatments in Patients With HBeAg-positive Chronic Hepatitis B in Thailand

BMC Health Services Research
Health Policy
2014English

Hepatitis B Serology in Patients With Rheumatic Diseases

Open Rheumatology Journal
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy